Quinones as Neuroprotective Agents

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Quinones exhibit dual cytoprotective and cytotoxic effects in neurodegenerative diseases.
• Low-dose, moderately electrophilic quinones activate the Keap1/Nrf2 pathway, inducing detoxifying enzymes.
• Natural quinones like coenzyme Q10 are vital for cellular energy and exhibit neuroprotection.

Purpose of the Study:

• To explore the multifaceted roles of quinones in neurodegenerative disease treatment.
• To identify and categorize natural and synthetic quinones with neuroprotective properties.
• To highlight the mechanisms underlying quinone-induced cytoprotection.

Main Methods:

• Literature review and analysis of existing studies on quinone bioactivity.
• Categorization of quinones based on their origin (endogenous/non-endogenous) and structural similarities.
• Examination of quinone interactions with cellular pathways, particularly Keap1/Nrf2.

Main Results:

• Coenzyme Q10, idobenone, mitoquinone, and plastoquinone demonstrate neuroprotective effects relevant to Alzheimer's and Parkinson's diseases.
• Tocopherol-derived quinones (e.g., vatiquinone) and vitamin K also exhibit neuroprotective activities.
• Various non-endogenous quinones, including embelin, APX-3330, and hybrid structures, show potential neuroprotective benefits.

Conclusions:

• Quinones represent a promising class of compounds for neurodegenerative disease therapy.
• Understanding the dose-dependent and structural nuances of quinones is crucial for therapeutic development.
• Further research into novel quinone derivatives and hybrid structures may yield effective treatments.